Text or WhatsApp Richard at (808) 600-9260
Lion crestHealthcareInvestmentBanking.com

Raising Capital from Physician Investors: Who They Are, How They Decide, and What to Check First

Physician investors write checks for businesses they can test against their own clinical and payer experience. Three things win the check: a company tied to one payer problem they feel every week, a physician on the team with a real vote, and a financial model they can read line by line. Settle two questions before the first meeting. First, which offering path will your securities attorney choose? Second, which prospects can refer patients to the company? Those investors need healthcare counsel to review the structure under federal referral and self-referral rules, and equal terms alone do not settle that review. The rest of this page covers segments, decision tests, round math and timing.

The Short Version

Data as of November 20, 2026. Every market figure below links to its source, with the counted population and period beside it. Worked examples, the SPV admin cost and the pipeline conversion rates are our own assumptions and arithmetic. They leave out offering costs, taxes, security terms and actual SPV expenses.

Quick-Start Checklist: Seven Steps Before the First Meeting

  1. Sort your list into three segments: employed physicians, former owners who sold, and current owners.
  2. Name the payer problem your company solves: payer rates, costly equipment or payer administration. Lead with one.
  3. Put a physician in the room with a defined role and a board or committee vote.
  4. Set the round math: target, minimum check, expected investor count and vehicle (worked examples 1 and 2).
  5. Flag every prospect who can refer patients to the company, in writing.
  6. Have your securities attorney choose the offering path before any podcast mention, forum post or conference talk about the raise.
  7. Build the filing calendar if the money funds acquisitions or changes ownership of a provider. Back-schedule commitments from the earliest filing.

Our healthcare data room checklist covers the materials side of the same preparation.

Who Physician Investors Are: Three Segments, Three Sets of Constraints

Most fundraising advice pictures the doctor as a practice owner writing a check from the business. Today's prospect often invests as an individual, either as an employee or as a former owner bound by a recent sale. Test each segment's constraints in the first conversation.

Segment What they bring What can block the check First question to ask
Employed physicians (hospital or platform) Steady income, clinical credibility Employment agreement limits on outside or competing ownership, hospital conflict-of-interest policies, referral relationships "Does your contract or hospital policy restrict outside investments?"
Former owners who sold to a hospital or PE platform Sale proceeds, firsthand knowledge of practice economics Noncompetes, rollover equity, consent rights held by the buyer "Does any covenant from your sale reach this deal?"
Current owners Operator judgment on margins, staffing and payer mix Capital tied up in their own practice, possible referral overlap with your company "Could your practice refer patients to us?"

Former owners need the most screening. A former owner in your specialty already understands the business, and a local one can walk the site. A seller's noncompete tends to cover exactly that: same specialty, same area. Some have sold twice. Bain's Global Healthcare Private Equity Report 2026 notes that Cardinal Health acquired GI Alliance from a group of physician owners and Apollo Global Management. Physicians in a chain like that can hold layered rollover and covenant terms. Tag your list by specialty and distance and collect each former owner's written answer on surviving covenants. Enforceability turns on state law as well as contract text, and some states now limit these clauses in physician practice agreements. Georgetown's Center on Health Insurance Reforms describes one state's approach.

Income is not wealth, and a title is not a balance sheet. Specialty, age and salary do not establish accredited status. Use one method, set by your securities attorney for your offering path, to check every investor, and keep the records.

Where Physician Money Comes From: The Deal Data Behind Your Prospect List

The deal flow of the last five years built the investor pool you are calling now. The series below count different things. Bain reports a share of global provider deals. PESP counts private equity deals involving US outpatient care providers. Kaufman Hall counts announced US hospital and health system transactions. All three count deals, not dollar value. The PESP figures come from Becker's reporting, which does not describe PESP's tracking method or denominator, so treat them as directional. Read each series on its own terms.

Data point (population and period) Figure Source What it means for your list
Physician groups as a share of all global provider transactions, 2021 vs 2025 28% in 2021, 23% in 2025 Bain & Company, Global Healthcare PE Report 2026 Fewer new platform sales. Bain reports physician groups remain a major part of many PE portfolios, so former owners field calls from many sponsors.
Deals involving US outpatient care providers in PESP's private equity tracking, calendar 2025 148 total, including 119 add-ons PESP data reported by Becker's ASC Review Our arithmetic: 119 / 148 = 80.4% add-ons. Many of these sellers likely joined an existing platform, so ask each one about rollover equity.
Top outpatient subsectors by deal count, same PESP dataset, calendar 2025 Dermatology 24, eye care 22, oncology 9 PESP data reported by Becker's ASC Review Expect recent sellers to cluster in dermatology and eye care, and screen every former owner for covenants.
Announced US hospital and health system transactions, January 1 to September 30, 2026 56 (22 in Q1, 18 in Q2, 16 in Q3) Kaufman Hall data reported by Becker's Hospital Review. Q3 count confirmed in the Kaufman Hall Q3 2026 M&A report, October 13, 2026 Quarterly counts fell each quarter (22, 18, 16), but every deal can add employed physicians whose contracts you need to read.

The spending base under these deals keeps growing. Per the CMS National Health Expenditure fact sheet, physician and clinical services remain one of the largest categories of national health spending. In the fact sheet edition covering 2024 data, Medicare spending reached $1,118.0 billion in 2024, 21% of national health spending. That share is one reason federal referral rules matter to many physician-facing businesses.

Bain also reports that the value-creation playbook for physician groups now reaches past buy-and-build into operational efficiency, including AI and analytics. Former owners who lived through a PE hold will ask what your operating plan does beyond adding locations. Put that answer in the model, line by line.

The pool is mainly a US story. Per Bain, investment in scale physician groups is far less common in Europe, where national markets and regulation are fragmented. It is uncommon in Asia-Pacific, where provider deals center on health systems.

To see how comparable companies sized their rounds, search private offering notices on SEC EDGAR full-text search. These public filings can show offering size, amount sold and investor count for healthcare companies in your niche.

Pitch to the Payer Problem: Rates, Equipment and Administrative Load

Physicians deal with payers every week, which makes them the fastest check on your pitch. Three pressures sit behind most practice economics: payer rates, the cost of equipment and space, and the administrative load of credentialing, prior authorization and billing. If you cannot tie your company to one of them in a single sentence, you are pitching a generic return that competes with every index fund the doctor already owns.

Pressure Company that answers it Question the physician will ask
Payer rates MSO contracting with payers as a larger group "Which payers have you renegotiated with, and what changed?"
Costly resources Platform funding imaging or surgical equipment "Who owns the equipment, and who pays if volume falls?"
Payer administration Back office for credentialing and prior authorization "How many hours a week does this save my staff?"

Then ask the prospect, "Which of these three costs you the most time?" Show where your company takes that work off their plate. For MSO mechanics, see our guide to management services organizations.

How Physicians Decide: A Meeting-Prep Framework

The table below is our own prep framework, not survey findings.

What the physician tests How it shows up in the meeting What to bring
What could go wrong Asks for failure cases before the upside A downside case that names the assumption that breaks it
Whether claims have data Discounts any number without a source A source for every model input, unit economics by provider or site
What a trusted colleague thinks Checks with a peer before committing A one-page summary cleared for sharing under your offering path
Whether it fits their schedule Reviews between cases, on call, late at night A 20-minute walkthrough and a data room they can read alone

Ask, "What would you need to see before you put this money at risk?" Answer with downside cases. Have your physician team member invest on the same terms as everyone else and disclose it in the offering documents.

The short deck built for institutional investors works poorly here. Physicians want the inner workings.

Meeting block What to show Why physicians ask for it
Model walkthrough Each revenue and cost line, with the source of every assumption They want to see how the business runs, not a summary
Unit economics Results per provider, per location or per procedure They check these against their own practice
Clinical workflow map Intake through coding, billing and collections Exposes weak points a clinician spots fast
Key-person risk Revenue impact if a lead physician leaves Former owners dealt with this in their own sales
Stage fit Why this stage suits this investor, or why it does not First-time private investors need an education step before the ask

Peer leadership gets the first meeting. In practice that means:

Peer trust also cuts diligence short. A physician who backs a deal because "a surgeon runs it" has skipped a step. Give physician investors the same disclosure and data room you would give an institution.

Structuring Physician Money: Vehicle Choice and Four Worked Examples

Price the debt alternative first

Equity from physicians is not the only option for a practice-scale need. The SBA 7(a) program is the SBA's main small business loan program. Ask a lender whether your need fits within its loan limits and terms.

Question Physician equity 7(a) or bank debt
What it costs Ownership (25% of the company in worked example 2) Interest, fees and repayment from cash flow
Who you answer to Dozens of physician holders, or one SPV manager One lender and its covenants
Best fit Growth with uncertain near-term cash flow, or where physician alignment has strategic value Stable cash flow that can service debt

Choose the vehicle before the first call

Vehicle How it works Strengths Weaknesses Best fit
Direct on the cap table Each physician buys shares or units in the company Simple story, each investor sees the company directly Many small holders, consent management on every vote, harder later rounds A small group of larger checks (few enough holders that collecting every consent stays manageable)
Single-purpose vehicle (SPV) Physicians invest in one LLC that holds a single line on the company's cap table One holder for the company, clean cap table for later investors Separate formation, tax reporting and admin cost, a manager must run it A physician syndicate of many small checks
Fund or club vehicle A pooled vehicle invests across several companies or practices Diversification, repeat use for later deals Highest setup cost, manager economics, longer to launch A repeat sponsor or physician network doing several deals

An SPV raises its own securities questions, including how its members are counted and who may invest. Confirm how the vehicle is treated with your securities attorney before treating it as a single holder.

Worked example 1: sizing the round and counting checks (illustrative, our arithmetic)

The minimum check sets a ceiling on investor count, not the count itself. For a $4.0 million round, the most checks you could take is the round divided by the minimum.

Minimum check Maximum possible investors ($4.0M / minimum)
$25,000 160
$50,000 80
$100,000 40
$250,000 16

The real count depends on the mix. Assumptions for one illustrative syndicate: $4.0 million raise, $50,000 minimum, check sizes below.

Check size Number of investors Capital
$250,000 4 $1,000,000
$100,000 20 $2,000,000
$50,000 20 $1,000,000
Total 44 $4,000,000

Average check: $4,000,000 / 44 = $90,909 (rounded). Forty-four direct holders means 44 parties to manage on every consent, unless the operating agreement carries drag-along and voting provisions that let a majority act for the group. That administrative load is the argument for an SPV. Raising the minimum to $100,000 keeps the four $250,000 checks ($1.0 million) and fills the remaining $3.0 million with 30 checks of $100,000 (4 × $250,000 + 30 × $100,000 = $4.0 million). That is 4 + 30 = 34 investors.

Worked example 2: what each physician owns (illustrative, our arithmetic)

Base case assumptions: $12.0 million pre-money valuation, $4.0 million raised, no option pool change, one class of equity, ownership measured on gross proceeds before offering costs.

Variant with an option pool, measured fully diluted (every issued share plus the full pool, granted or not, counted as outstanding): the term sheet requires a new pool equal to 10% of the post-money fully diluted capitalization, created inside the $12.0 million pre-money. The share price is set by dividing $12.0 million by existing shares plus the new pool. Assume 6,500,000 existing shares. The pool is 1,000,000 shares (10% of 10,000,000 post-money fully diluted shares), so the pre-money fully diluted count is 7,500,000 and the price is $12.0 million / 7,500,000 = $1.60 per share. New investors buy $4.0 million / $1.60 = 2,500,000 shares, for a total of 6,500,000 + 1,000,000 + 2,500,000 = 10,000,000 fully diluted shares. New investors own 2,500,000 / 10,000,000 = 25.0%, and the $100,000 physician buys 62,500 shares, or 0.625%. Existing holders absorb the pool and fall to 100% minus 25% minus 10% = 65.0%. Preferred terms, convertible notes and later rounds would change these figures again, so show the fully diluted table in the meeting, not only the dollar amount.

Worked example 3: distributions tied to capital, not referrals (illustrative, our arithmetic)

Assumptions: an SPV holds $2.0 million from 20 physicians. The company distributes $300,000 to the SPV in a year. The SPV passes cash through pro rata to capital. Annual SPV admin cost of $20,000 is our assumption and varies by manager and service provider. Figures are before tax.

Line Gross of SPV costs Net of $20,000 SPV admin cost
Cash available to SPV members $300,000 $300,000 minus $20,000 = $280,000
Cash yield on $2.0M capital 15.0% 14.0%
Share for a $150,000 investor (7.5% of SPV) 7.5% × $300,000 = $22,500 7.5% × $280,000 = $21,000

The investor's share is $150,000 / $2,000,000 = 7.5% in both columns. That payout is the same whether the physician referred 500 patients or none. If any term, bonus, share class or allocation moves with how much business an investor sends the company, fix it. Passing this screen does not make a structure compliant under federal referral rules, so your healthcare attorney still reviews it.

Worked example 4: building the pipeline backward (illustrative, our assumed rates)

These rates are planning assumptions, not industry benchmarks: 40% of physicians contacted take a first meeting, and 25% of first meetings convert to a commitment.

Replace both rates with your own after the first 30 meetings. If conversion runs at 15%, first meetings needed rise to 44 / 0.15 = 293.3, rounded up to 294, and contacts to 294 / 0.40 = 735. A founder who budgets for 176 meetings and needs 294 runs out of runway mid-raise.

Investors Who Can Refer Patients: How to Build Clean Terms

A physician investor who can send patients to the company changes the deal. Federal fraud and abuse laws govern ownership and payments tied to referrals, and HHS OIG's guide to fraud and abuse laws gives physicians a plain-language overview. Whether a given structure is acceptable depends on who invests, how returns are paid and where the company's business comes from. The High-risk area box on this page lists the questions to bring to your healthcare attorney.

An imaging or ancillary platform funded by the physicians who order its scans sits at the center of these rules. Physician ownership of hospitals carries its own separate federal restrictions, so treat any physician raise for hospital ownership as a separate legal project from day one.

Practices that keep terms clean in any structure:

Practice The reason
Flag every investor who can refer, in writing, before term sheets The structure depends on the list
One share class, one price, one set of terms for referring and non-referring investors Different terms for referral sources draw scrutiny
Distributions pro rata to capital invested Shown in worked example 3
No minimum referral, volume or loyalty expectation, written or spoken Sales talk in a pitch meeting can become evidence
Same diligence package for every investor Keeps disclosure consistent across physicians and institutions
Disclose physician team members' investments in the offering documents Physicians will ask, and the answer should already be in writing

Run the worked example 3 test on every draft term sheet. Recompute one referring and one non-referring investor's payout at the same check size. If the two numbers differ, find the term that causes it before the draft goes out.

For the diligence side, see our healthcare compliance due diligence guide.

Choosing the Offering Path

A private raise from physicians is a securities offering. The offering path you choose affects whether you can advertise the raise, who can invest and how investors are checked. Your securities attorney decides that before any outreach. Tie the choice to your outreach plan: a warm network of colleagues you already know points one way, and broad outreach through physician media and events points another.

Your attorney will also screen the people running the offering before anyone pitches. If anyone will be paid for introductions or for raising money, look them up on FINRA BrokerCheck before you sign a fee agreement.

Pre-Outreach Screening: A Decision Table

Sort each prospect and each deal feature before anyone is contacted.

Fact about the investor or deal What to do before the first meeting Gate
Investor can refer patients to the company Add to the referring-investor list, run the worked example 3 test No term sheet until your healthcare attorney clears the structure under federal referral rules
Investor is hospital-employed Get contract and conflict-of-interest status in writing Written answer before the term sheet
Investor sold a practice in the last few years Get a written answer on surviving covenants and rollover equity Written answer before the second meeting
Anyone will be paid for introductions Check BrokerCheck, hold all fee agreements No fee agreement until registration status is confirmed
Raise funds practice acquisitions Build the state list and filing calendar Commitment deadline set from the calendar
Raise will be mentioned publicly Confirm with your securities attorney that the offering path allows it and set the investor check process No public mention until counsel clears it
Physician investors want board seats or control rights List exactly what you plan to offer, check state corporate practice of medicine limits Governance terms fixed before the term sheet

The deal file to assemble before terms go out

Using the figures on this page, a founder running the $4.0 million example round would assemble:

High-risk area: Physician investors who refer patients, and raising from them

Physician ownership, patient referrals and private securities offerings turn on your state, structure and facts. Bring these questions to a healthcare attorney and a securities attorney.

Questions to ask your attorney

1. How should we structure terms for physician investors who can refer patients to the company?

  • Why ask: Referral relationships can affect share classes, pricing, distributions and who may invest at all.
  • What can go wrong: Terms or side conversations that appear to reward referrals draw government scrutiny and can lead to costly investigations or settlements.
  • Example: On December 18, 2023 the U.S. Department of Justice announced that Community Health Network, an Indianapolis health system, agreed to pay $345 million to resolve allegations that it paid recruited specialists above fair market value and paid bonuses tied to referrals, then billed Medicare for the referred services. The case began with a whistleblower complaint filed in 2014 by the system's former CFO and COO. The system denied the allegations and entered a five-year Corporate Integrity Agreement. It concerned physician pay rather than investment returns, but it shows the scrutiny payments linked to referrals attract. U.S. Department of Justice

2. Which offering path should our raise use, given where we plan to talk about it?

  • Why ask: The path decides whether you may promote the raise publicly and who may then invest.
  • What can go wrong: Depending on the facts, an early public mention can close off an offering path for the raise.

3. How should we verify each physician's investor status, and what records should we keep?

  • Why ask: Specialty, title or salary do not settle the question, and the method depends on the path.
  • What can go wrong: Inconsistent checks across 44 investors leave gaps that surface in a later round or a sale.

4. Could the acquisitions this raise funds, or the investment itself, trigger state transaction notice or review?

  • Why ask: Notice or review steps can sit between signing and closing and set your real commitment deadline.
  • What can go wrong: A missed or late filing can delay closing or put funded acquisitions at risk.
  • How states have handled it: Massachusetts, January 2025: the legislature announced a law expanding the state's review of health care transactions to cover private equity investors and management services organizations. Massachusetts Legislature

5. What board seats, votes and control rights can we offer physician investors in an MSO or clinical entity in our states?

  • Why ask: State corporate practice of medicine rules shape who may own or control a clinical entity and what governance you may promise.
  • What can go wrong: Promising control you cannot deliver forces a restructure mid-raise and damages investor trust.
  • How states have handled it: Oregon, 2025: the state passed a corporate practice of medicine law that limits the "friendly physician" model and MSO control of physician practices, with compliance dates that vary by arrangement. Georgetown CHIR

6. Can we pay anyone who introduces physician investors or helps run the raise?

  • Why ask: Fees tied to money raised raise broker-dealer registration questions for the person paid and for the company.
  • What can go wrong: An improper fee arrangement can give investors grounds to unwind their investment.

7. How should our SPV or fund be set up so it holds up under our offering path and referral review?

  • Why ask: The vehicle and the owners inside it each need review, not only the company.
  • What can go wrong: A vehicle formed before the review may need to be rebuilt, adding cost and delay.

Other topics to raise with your attorney

  • Federal and state securities filings for the offering
  • Tax treatment of the vehicle, distributions and any rollover equity from a prior sale
  • Whether larger acquisitions funded by the raise need federal antitrust premerger review
  • Background screening of everyone involved in running the offering
  • What the offering documents should disclose about physician team members' investments
  • How to handle physicians whose employment contracts or sale covenants restrict investing

Timing the Raise Around Acquisitions

When physician capital funds practice acquisitions through an MSO or PE-backed platform, state notice or review steps can sit between signing and closing. Which apply, and how long they take, varies by state and by deal. Commitments need to be signed early enough that funding never holds up a filing.

Step Owner Output
1. List every state where a target practice operates Deal team State list
2. Identify filings and review steps in each state Regulatory counsel Filing calendar
3. Mark the earliest filing date across all states Deal team Binding date
4. Subtract document prep time for the filing Deal team Terms-final date
5. Subtract your buffer for late signatures Founder Commitment deadline

For a multi-state deal, the deadline for signed physician commitments is the earliest filing date, less prep time, less your buffer. A review step with no fixed clock deserves the widest buffer, since you cannot back-schedule from a date you do not control. For more, see the healthcare M&A process guide.

Running the Raise: Who Makes the Calls, How Long It Takes and How to Size the First Check

Decision Practice Physician-specific application
Who makes the calls The founder raises the capital directly The physician-founder owns the calls. Anyone paid to talk to investors is checked on BrokerCheck first.
Timeline Raises run longer than the founder's first plan Plan for the conversion shortfall in worked example 4 and still meet the commitment deadline.
First meeting Listen first. Out of a full deck, the investor may care about one slide. Take the history before writing the prescription. Open with the payer question.
First check size New investors often test a deal with a small first check A lower minimum or a staged first close suits a physician new to private deals. Weigh that against the investor ceiling in worked example 1.
List building AI tools can screen large sets of investor bios for healthcare focus and location Filtering is not outreach, so the offering-path gate above still applies.
Follow-up Physician relationships build over years, often through education before any ask Keep employed physicians and recent sellers on the list after a "no." Covenants expire and contracts change.

For the wider investor universe, see finding healthcare investors, family office healthcare investing, the healthcare pitch deck guide, capital raising for healthcare companies, selling a physician practice, private equity physician roll-ups and the white paper Raising Capital for Healthcare Companies Without a Bank.

Questions Practice Owners and Investors Ask

Which physicians make the best first prospects for a healthcare raise?

Former practice owners who sold to a PE platform or hospital have the most liquid capital and the deepest feel for practice economics. They also carry the most obligations from the sale, such as noncompetes, rollover equity and buyer consent rights. Treat them as the highest-potential and highest-screening segment. Get a written answer on surviving covenants before the second meeting. Specialty and salary do not establish accredited status, so verify it the same way for every investor.

Does raising physician money for an MSO or PE-backed practice platform trigger a state filing?

The raise is a securities offering, which can bring federal and state securities filings that your securities attorney will map out. The practice acquisitions it funds can trigger separate state healthcare transaction notice or review, and some states also cover equity investments in provider entities. Build the filing calendar before you set a closing date, then schedule physician commitments ahead of the earliest filing.

Can we mention our raise on a physician podcast or in an online physician forum?

Not until your securities attorney has chosen the offering path. A private raise from physicians is a securities offering, and the path you choose affects whether you can advertise it and how investors are checked. Settle that before anyone on your team mentions the raise in public, on a podcast or in a physician group chat, because an early public mention can limit your options.

Can a hospital-employed physician invest in a healthcare startup or MSO?

Many can. Employment agreements and hospital conflict-of-interest policies often restrict outside or competing ownership, so get the physician's written answer before the term sheet. If the physician can refer patients to the company, federal referral and self-referral rules may apply, so have a healthcare attorney review the relationship. Price every investor the same way and tie returns to capital invested, never to referrals.

Sources